Français
Español
English

Meeting of the Parties to the Montreal Protocol

Prev || Next

Decision XVII/45: Endorsement of new co-chairs of the technical options committees of the Technology and Economic Assessment Panel

The Seventeenth Meeting of the Parties decided in Dec. XVII/45:

  1. To endorse the following new Co-Chairs of the Technical Options Committees:
    1. Halon Technical Options Committee: David Catchpole and Dan Verdonik;
    2. Methyl Bromide Technical Options Committee: Michelle Marcotte, Ian Porter, Mohamed Besri and Marta Pizano;
    3. Chemicals Technical Options Committee: Ian Rae and Masaaki Yamabe;
  2. To thank the following Co-Chairs who are stepping down from their positions, for their outstanding efforts on behalf of the Montreal Protocol:
    1. Jonathan Banks (Methyl Bromide Technical Options Committee);
    2. Nahum Marban-Mendoza (Methyl Bromide Technical Options Committee).

Select another type of Meeting

23rd MOP Decisions
Dec. XXIII/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol
Dec. XXIII/2: Essential-use nominations for controlled substances for 2012
Dec. XXIII/3: Essential-use exemption for chlorofluorocarbon‑113 for aerospace applications in the Russian Federation
Dec. XXIII/4: Critical-use exemptions for methyl bromide for 2013
Agreed critical-use categories for 2013
Dec. XXIII/5: Quarantine and pre-shipment uses of methyl bromide
Dec. XXIII/6: Global laboratory and analytical-use exemption
Dec. XXIII/7: Use of controlled substances as process agents
Dec. XXIII/8: Investigation of carbon tetrachloride discrepancy
Dec. XXIII/9: Additional information on alternatives to ozone‑depleting substances
Dec. XXIII/10: Updating the nomination and operational processes of the Technology and Economic Assessment Panel and its subsidiary bodies
Dec. XXIII/11: Montreal Protocol treatment of ozone‑depleting substances used to service ships, including ships from other flag states
Dec. XXIII/12: Adoption of new destruction technologies for ozone‑depleting substances
Dec. XXIII/13: Potential areas of focus for the 2014 quadrennial reports of the Scientific Assessment Panel, the Environmental Effects Assessment Panel and the Technology and Economic Assessment Panel
Dec. XXIII/14: Key challenges facing methyl bromide phase-out in parties operating under paragraph 1 of Article 5
Dec. XXIII/15: 2012–2014 replenishment of the Multilateral Fund
Dec. XXIII/16: Extension of the fixed-exchange-rate mechanism to the 2012–2014 replenishment of the Multilateral Fund
Dec. XXIII/17: Administrative and financial matters: financial reports and budgets
Dec. XXIII/18: Membership of the Implementation Committee
Dec. XXIII/19: Membership of the Executive Committee of the Multilateral Fund
Dec. XXIII/20: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XXIII/21: Endorsement of a new co-chair of the Chemicals Technical Options Committee and a senior expert of the Technology and Economic Assessment Panel
Dec. XXIII/22: Data and information provided by the parties in accordance with Article 7 of the Montreal Protocol
Dec. XXIII/23: Potential non-compliance in 2009 with the provisions on consumption of the controlled substances in Annex A, group II (halons), by Libya and request for a plan of action
Dec. XXIII/24: Difficulties faced by Iraq as a new party
Dec. XXIII/25: Non-reporting of 2009 data on hydrochlorofluorocarbons by Yemen in accordance with Article 7 of the Montreal Protocol
Dec. XXIII/26: Non-compliance with the Montreal Protocol by the European Union
Dec. XXIII/27: Non-compliance with the Montreal Protocol by the Russian Federation
Dec. XXIII/28: Request by Tajikistan for the revision of its baseline data
Dec. XXIII/29: Requests for the revision of baseline data by Barbados, Bosnia and Herzegovina, Brunei Darussalam, Guyana, Lao People’s Democratic Republic, Lesotho, Palau, Solomon Islands, Swaziland, Togo, Tonga, Vanuatu and Zimbabwe
Dec. XXIII/30: Decimal places to be used by the Secretariat in analysing and presenting hydrochlorofluorocarbon data for 2011 and later years
Dec. XXIII/31: Status of the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XXIII/32: Twenty-Fourth Meeting of the Parties to the Montreal Protocol
Dec. XXIII/33: Twenty-Sixth Meeting of the Parties to the Montreal Protocol
Dec. XXIII/I: Annex I: Trust fund for the Vienna Convention for the protection of the ozone layer: approved 2011 and 2012 and proposed 2013 and 2014 budgets (in United States dollars)
Dec. XXIII/II: Annex II: Trust Fund for the Vienna Convention for the Protection of the Ozone Layer
Dec. XXIII/III: Annex III: Contributions by parties to the eighth replenishment of the Multilateral Fund (2012, 2013 and 2014)
Dec. XXIII/IV: Annex IV: Trust fund for the Montreal Protocol on substances that deplete the ozone layer Approved 2011 and 2012 and proposed 2013 budgets (in United States dollars)
Dec. XXIII/V: Annex V: Trust Fund for the Montreal Protocol on the Substances that Deplete the Ozone Layer
Dec. XXIII/VI: Annex VI: Summaries of presentations by members of the assessment panels and technical options committees during the preparatory segment
Dec. XXIII/VII: Annex VII: Draft decision XXIII/[  ]: Funding for hydrochlorofluorocarbon production facilities
Dec. XXIII/VIII: Annex VIII: Summary of presentation on the eighth meeting of the Ozone Research Managers of the Parties to the Vienna Convention
Dec. XXIII/IX: Annex IX: Bali Declaration
Dec. XXIII/X: Annex X: Summaries of presentations by members of the assessment panels on the 2010 quadrennial assessment during the high-level segment
==== SHOW ALL ====
22nd MOP Decisions
Dec. XXII/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol
Dec. XXII/2: Terms of reference for an evaluation of the financial mechanism of the Montreal Protocol
Dec. XXII/3: Terms of reference for the study on the 2012-2014 replenishment of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XXII/4: Essential-use nominations for controlled substances for 2011
Dec. XXII/5: Essential-use exemption for chlorofluorocarbon 113 for aerospace applications in the Russian Federation
Dec. XXII/6: Critical-use exemptions for methyl bromide for 2011 and 2012
Dec. XXII/7: Global laboratory and analytical use exemption
Dec. XXII/8: Uses of controlled substances as process agents
Dec. XXII/9: Hydrochlorofluorocarbons preblended in polyols
Dec. XXII/10: Destruction technologies with regard to ozone-depleting substances
Dec. XXII/11: Progress by the International Civil Aviation Organization in the transition from the use of halon
Dec. XXII/12: Situation of Haiti
Dec. XXII/13: Non-compliance with the Montreal Protocol by Singapore
Dec. XXII/14: Data and information provided by the parties in accordance with Article 7 of the Montreal Protocol
Dec. XXII/15: Non-compliance with the Montreal Protocol by Saudi Arabia
Dec. XXII/16: Non-compliance with the Montreal Protocol by the Republic of Korea
Dec. XXII/17: Ratification of the Copenhagen, Montreal and Beijing amendments to the Montreal Protocol by Kazakhstan
Dec. XXII/18: Non-compliance with the Montreal Protocol by Vanuatu
Dec. XXII/19: Status of establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XXII/20: Treatment of stockpiled ozone-depleting substances
Dec. XXII/21: Administrative and financial matters: financial reports and budgets
Dec. XXII/22: Membership changes on the assessment panels
Dec. XXII/23: Membership of the Implementation Committee
Dec. XXII/24: Membership of the Executive Committee of the Multilateral Fund
Dec. XXII/25: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XXII/26: Twenty-Third Meeting of the Parties to the Montreal Protocol
Dec. XXII/Anx I: Annex I - Trust Fund for the Montreal Protocol on Substances that Deplete the Ozone Layer
Dec. XXII/Anx II: Annex II - Trust Fund for the Montreal Protocol on Substances that Deplete the Ozone Layer
Dec. XXII/Anx III: Annex III - Declaration on the global transition away from hydrochlorofluorocarbons (HCFCs) and chlorofluorocarbons (CFCs)
==== SHOW ALL ====
21st MOP Decisions
Dec. XXI/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol
Dec. XXI/2: Environmentally sound management of banks of ozone‑depleting substances
Dec. XXI/3: Uses of controlled substances as process agents
Dec. XXI/4: Essential-use nominations for controlled substances for 2010
Dec. XXI/5: Essential-use exemption for chlorofluorocarbon-113 for aerospace applications in the Russian Federation
Dec. XXI/6: Global laboratory use exemption
Dec. XXI/7: Management and reduction of remaining uses of halons
Dec. XXI/8: Sources of carbon tetrachloride emissions and opportunities for reductions of ODS emissions
Dec. XXI/9: Hydrochlorofluorocarbons and environmentally sound alternatives
Dec. XXI/10: Quarantine and pre-shipment uses of methyl bromide
Dec. XXI/11: Critical-use exemptions for methyl bromide for 2010 and 2011
Dec. XXI/12: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XXI/13: Endorsement of the new co-chair of the Refrigeration, Air Conditioning and Heat Pumps Technical Options Committee of the Technology and Economic Assessment Panel
Dec. XXI/14: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XXI/15: Reporting of methyl bromide for quarantine and pre‑shipment use
Dec. XXI/16: Membership of the Implementation Committee
Dec. XXI/17: Non-compliance in 2007 and 2008 with the provisions of the Protocol governing consumption of the controlled substances in Annex A, group I (chlorofluorocarbons), by Bangladesh
Dec. XXI/18: Non-compliance in 2007 and 2008 with the provisions of the Protocol governing consumption of the controlled substances in Annex A, group I (chlorofluorocarbons), by Bosnia and Herzegovina
Dec. XXI/19: Compliance with the Montreal Protocol by the Federated States of Micronesia
Dec. XXI/20: Non-compliance in 2008 with the provisions of the Protocol governing consumption of the controlled substance in Annex B, group II (carbon tetrachloride), by Mexico
Dec. XXI/21: Non-compliance in 2007 with the provisions of the Protocol governing consumption of the controlled substances in Annex A, group I ( chlorofluorocarbons ), by Saudi Arabia and request for a plan of action
Dec. XXI/22: Compliance with the Montreal Protocol by Solomon Islands
Dec. XXI/23: Non-compliance with the Montreal Protocol by Somalia
Dec. XXI/24: Difficulties faced by Timor-Leste as a new Party
Dec. XXI/25: Non-compliance in 2007 with the provisions of the Protocol governing consumption of the controlled substance in Annex B, group II (carbon tetrachloride), by Turkmenistan and request for a plan of action
Dec. XXI/26: Non-compliance in 2007 and 2008 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex A group I (CFCs), by Vanuatu and request for a plan of action
Dec. XXI/27: Membership of the Executive Committee of the Multilateral Fund
Dec. XXI/28: Evaluation of the financial mechanism of the Montreal Protocol
Dec. XXI/29: Institutional strengthening
Dec. XXI/30: Twenty‑Second Meeting of the Parties to the Montreal Protocol
Dec. XXI/31: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XXI/32:   Financial matters: Financial reports and budgets
==== SHOW ALL ====
20th MOP Decisions
Dec. XX/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol
Dec. XX/2: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2009 and 2010
Dec. XX/3: Essential-use exemptions for Parties operating under paragraph 1 of Article 5
Dec. XX/4: Campaign production of chlorofluorocarbons for metered-dose inhalers
Dec. XX/5: Critical-use exemptions for methyl bromide for 2009 and 2010
Dec. XX/6: Actions by Parties to reduce methyl bromide use for quarantine and pre‑shipment purposes and related emissions
Dec. XX/7: Environmentally sound management of banks of ozone­depleting substances
Dec. XX/8: Workshop for a dialogue on high-global warming potential alternatives for ozone‑depleting substances
Dec. XX/9: Application of the Montreal Protocol’s trade provisions to hydrochlorofluorocarbons
Dec. XX/10: 2009–2011 replenishment of the Multilateral Fund
Dec. XX/11: Extension of the fixed‑exchange‑rate mechanism to the 2009–2011 replenishment of the Multilateral Fund
Dec. XX/12: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XX/13: Reports of Parties submitted under Article 9 of the Montreal Protocol
Dec. XX/14: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XX/15: Difficulties faced by Iraq as a new Party
Dec. XX/16: Non-compliance with the Montreal Protocol by Ecuador
Dec. XX/17: Request for change in baseline data by Saudi Arabia
Dec. XX/18: Potential non-compliance in 2006 with the provisions of the Montreal Protocol in respect of consumption of the controlled substances in Annex A, group I, (chlorofluorocarbons) by Solomon Islands and request for a plan of action and data for the year 2007
Dec. XX/19: Non-compliance with the provisions of the Montreal Protocol in respect of consumption of the controlled substances in Annex A, groups I (chlorofluorocarbons) and II (halons) by Somalia
Dec. XX/20:   Montreal Protocol financial matters: financial reports and budgets
Dec. XX/21: Membership of the Implementation Committee
Dec. XX/22: Membership of the Executive Committee of the Multilateral Fund
Dec. XX/23: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XX/24: Endorsement of new co-chair of the Halons Technical Options Committee of the Technology and Economic Assessment Panel
Dec. XX/25: Twenty‑First Meeting of the Parties to the Montreal Protocol
Dec. XX/26: Adoption of the Doha Declaration
==== SHOW ALL ====
19th MOP Decisions
Dec. XIX/1: Ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Protocol
Dec. XIX/2: Membership of the Implementation Committee
Dec. XIX/3: Membership of the Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XIX/4: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XIX/5: Financial matters: financial reports and budgets
Dec. XIX/6: Adjustments to the Montreal Protocol with regard to Annex C, Group I, substances (hydrochlorofluorocarbons)
Dec. XIX/7: Eligibility of South Africa for financial assistance from the Multilateral Fund
Dec. XIX/8: Additional work on hydrochlorofluorocarbons
Dec. XIX/9: Critical-use exemptions for methyl bromide for 2008 and 2009
Dec. XIX/10: Terms of reference for the study on the 2009–2011 replenishment of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XIX/11: Revision of the terms of reference of the Executive Committee
Dec. XIX/12: Preventing illegal trade in ozone-depleting substances
Dec. XIX/13: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2008 and 2009
Dec. XIX/14: Essential-use exemption for chlorofluorocarbon‑113 for aerospace applications in the Russian Federation
Dec. XIX/15: Replacement of table A and table A‑bis in relevant process agent decisions
Dec. XIX/16: Follow-up to the 2006 assessment report by the Halons Technical Options Committee
Dec. XIX/17: Use of carbon tetrachloride for laboratory and analytical uses in Parties operating under paragraph 1 of Article 5 of the Montreal Protocol
Dec. XIX/18: Laboratory and analytical‑use exemption
Dec. XIX/19: Request by Romania to be removed from the list of developing countries under the Montreal Protocol
Dec. XIX/20: Terms of reference for the Scientific Assessment Panel, the Environmental Effects Assessment Panel and the Technology and Economic Assessment Panel
Dec. XIX/21: Non-compliance in 2005 with the provisions of the Montreal Protocol governing production of the controlled substances in Annex A, group I, (chlorofluorocarbons) and the requirements of Article 2 of the Protocol with regard to the transfer of CFC production rights by Greece
Dec. XIX/22: Non-compliance with the Montreal Protocol by Paraguay
Dec. XIX/23: Potential non-compliance in 2005 with the provisions of the Montreal Protocol governing consumption of the controlled substance in Annex E (methyl bromide) by Saudi Arabia and request for a plan of action
Dec. XIX/24: Request for change in baseline data by Turkmenistan
Dec. XIX/25: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XIX/26: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XIX/27: Compliance with the Montreal Protocol by the Islamic Republic of Iran
Dec. XIX/28: Implementation of paragraph 1 of decision XVII/12 with respect to the reporting of production of chlorofluorocarbons by Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol to meet the basic domestic needs of Parties operating under paragraph 1 of Article 5
Dec. XIX/29: Selection of new co-chairs of the Scientific Assessment Panel
Dec. XIX/30: Twentieth Meeting of the Parties to the Montreal Protocol
Dec. XIX/31: Montreal Declaration
==== SHOW ALL ====
18th MOP Decisions
Dec. XVIII/1: Membership of the Implementation Committee
Dec. XVIII/2: Membership of the Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XVIII/3: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XVIII/4: Co-chair of the Chemicals Technical Options Committee
Dec. XVIII/5: Financial matters: financial reports and budgets
Dec. XVIII/6: Ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Protocol
Dec. XVIII/7: Essential-use exemptions for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2007 and 2008
Dec. XVIII/8: Essential-use exemption for chlorofluorocarbon-113 for aerospace applications in the Russian Federation for 2007
Dec. XVIII/9: Review of draft terms of reference for case studies called for under decision XVII/17 on environmentally sound destruction of ozone-depleting substances
Dec. XVIII/10: Sources of carbon tetrachloride emissions and opportunities for reductions
Dec. XVIII/11: Sources of n-propyl bromide emissions, alternatives available and opportunities for reductions
Dec. XVIII/12: Future work following the Ozone Secretariat workshop on the Intergovernmental Panel on Climate Change/Technology and Economic Assessment Panel special report
Dec. XVIII/13: Critical-use exemptions for methyl bromide for 2007 and 2008
Dec. XVIII/14: Montreal Protocol/International Plant Protection Convention cooperation on the use of alternatives to methyl bromide for quarantine and pre­shipment
Dec. XVIII/15: Laboratory and analytical critical uses of methyl bromide
Dec. XVIII/16: Difficulties faced by some Article 5 Parties manufacturing metered-dose inhalers which use chlorofluorocarbons
Dec. XVIII/17: Treatment of stockpiled ozone-depleting substances relative to compliance
Dec. XVIII/18: Preventing illegal trade in ozone-depleting substances through systems for monitoring their transboundary movement between Parties
Dec. XVIII/19: Guidelines for disclosure of interest for groups such as the Technology and Economic Assessment Panel and its technical options committees
Dec. XVIII/20: Non-compliance with the Montreal Protocol by Armenia
Dec. XVIII/21: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex B, group II, (carbon tetrachloride) and Annex B, group III, (methyl chloroform) by the Democratic Republic of the Congo
Dec. XVIII/22: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex A, group I, (CFCs) by Dominica
Dec. XVIII/23: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substance in Annex E (methyl bromide) by Ecuador and request for a plan of action
Dec. XVIII/24: Potential non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex A, group I, (CFCs) by Eritrea and request for a plan of action
Dec. XVIII/25: Non-compliance with regard to the transfer of CFC production rights by Greece
Dec. XVIII/26: Revised plan of action to return Guatemala to compliance with the control measures in Article 2H of the Montreal Protocol
Dec. XVIII/27: Potential non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substance in Annex B group II, (carbon tetrachloride) by the Islamic Republic of Iran and request for a plan of action
Dec. XVIII/28: Non-compliance with the Montreal Protocol by Kenya
Dec. XVIII/29: Request for change in baseline data by Mexico
Dec. XVIII/30: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substance in Annex B, group II, (carbon tetrachloride) by Mexico
Dec. XVIII/31: Non-compliance with the Montreal Protocol by Pakistan
Dec. XVIII/32: Non-compliance in 2005 with the control measures of the Montreal Protocol governing consumption of the controlled substances in Annex A, group I, (CFCs) and Annex B, group II, (carbon tetrachloride) by Paraguay and request for a plan of action
Dec. XVIII/33: Non-compliance with data-reporting requirements for the purpose of establishing baselines under paragraphs 3 and 8 ter (d) of Article 5 by Serbia
Dec. XVIII/34: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XVIII/35: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XVIII/36: Dialogue on key future challenges to be faced by the Montreal Protocol
Dec. XVIII/37: Nineteenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
17th MOP Decisions
Dec. XVII/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol
Dec. XVII/2: Request by Cyprus to be removed from the list of developing countries under the Montreal Protocol
Dec. XVII/3: Application to Belgium, Poland and Portugal of paragraph 8 of Article 4 of the Montreal Protocol with respect to the Beijing Amendment to the Montreal Protocol
Dec. XVII/4: Application to Tajikistan of paragraph 8 of Article 4 of the Montreal Protocol with respect to the Beijing Amendment to the Montreal Protocol
Dec. XVII/5: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2006 and 2007
Dec. XVII/6: Process agents
Dec. XVII/7: List of uses of controlled substances as process agents
Dec. XVII/8: List of uses of controlled substances as process agents
Dec. XVII/9: Critical-use exemptions for methyl bromide for 2006 and 2007
Dec. XVII/10: Laboratory and analytical critical uses of methyl bromide
Dec. XVII/11: Recapturing/recycling and destruction of methyl bromide from space fumigation
Dec. XVII/12: Minimizing production of chlorofluorocarbons by Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol to meet the basic domestic needs of Parties operating under paragraph 1 of Article 5
Dec. XVII/13: Use of carbon tetrachloride for laboratory and analytical uses in Parties operating under paragraph 1 of Article 5 of the Montreal Protocol
Dec. XVII/14: Difficulties faced by some Parties operating under paragraph 1 of Article 5 of the Montreal Protocol with respect to chlorofluorocarbons used in the manufacture of metered-dose inhalers
Dec. XVII/15: Coordination between the Ozone Secretariat and the Secretariat of the International Plant Protection Convention
Dec. XVII/16: Preventing illegal trade in controlled ozone-depleting substances
Dec. XVII/17: Technical and financial implications of the environmentally sound destruction of concentrated and diluted sources of ozone-depleting substances
Dec. XVII/18: Request for assistance of the Technology and Economic Assessment Panel for the meeting of experts on destruction
Dec. XVII/19: Consideration of the Technology and Economic Assessment Panel and Intergovernmental Panel on Climate Change assessment report as it relates to actions to address ozone depletion
Dec. XVII/20: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XVII/21: Non-compliance with data-reporting requirements under Articles 5 and 7 of the Montreal Protocol by Parties recently ratifying the Montreal Protocol
Dec. XVII/22: Non-compliance with data-reporting requirements for the purpose of establishing baselines under Article 5, paragraphs 3 and 8 ter (d)
Dec. XVII/23: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XVII/24: Reports of the Parties submitted under Article 9 of the Montreal Protocol on research, development, public awareness and exchange of information
Dec. XVII/25: Non-compliance with the Montreal Protocol by Armenia and request for a plan of action
Dec. XVII/26: Non-compliance with the Montreal Protocol by Azerbaijan
Dec. XVII/27: Non-compliance with the Montreal Protocol by Bangladesh
Dec. XVII/28: Non-compliance with the Montreal Protocol by Bosnia and Herzegovina
Dec. XVII/29: Non-compliance with the Montreal Protocol by Chile
Dec. XVII/30: Potential non-compliance in 2004 with consumption of the controlled substances in Annex B group I (other fully halogenated chlorofluorocarbons) by China, and request for a plan of action
Dec. XVII/31: Non-compliance with the Montreal Protocol by Ecuador
Dec. XVII/32: Non-compliance with the Montreal Protocol by Federated States of Micronesia
Dec. XVII/33: Non-compliance with the Montreal Protocol by Fiji
Dec. XVII/34: Revised plan of action to return Honduras to compliance with the control measures in Article 2H of the Montreal Protocol
Dec. XVII/35: Potential non-compliance in 2004 with the controlled substances in Annex A, group I (CFCs) by Kazakhstan, and request for a plan of action
Dec. XVII/36: Non-compliance with the Montreal Protocol by Kyrgyzstan
Dec. XVII/37: Non-compliance with the Montreal Protocol by the Libyan Arab Jamahiriya
Dec. XVII/38: Non-compliance with the Montreal Protocol by Sierra Leone, and request for a plan of action
Dec. XVII/39: Revised plan of action for the early phase-out of methyl bromide in Uruguay
Dec. XVII/40: The 2006-2008 replenishment of the Multilateral Fund
Dec. XVII/41: Fixed-exchange-rate mechanism for the replenishment of the Multilateral Fund
Dec. XVII/42: Financial matters: Financial reports and budgets
Dec. XVII/43: Membership of the Implementation Committee
Dec. XVII/44: Membership of the Executive Committee of the Multilateral Fund
Dec. XVII/45: Endorsement of new co-chairs of the technical options committees of the Technology and Economic Assessment Panel
Dec. XVII/46: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XVII/47: Dates of future Montreal Protocol meetings
Dec. XVII/48: Eighteenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
2nd ExMOP Decisions
Dec. Ex.II/1: Critical-use exemptions for methyl bromide
16th MOP Decisions
Dec. XVI/1: Ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Protocol l
Dec. XVI/2: Critical use exemptions for methyl bromide for 2005 and 2006
Dec. XVI/3: Duration of critical-use nominations of methyl bromide
Dec. XVI/4: Review of the working procedures and terms of reference of the Methyl Bromide Technical Options Committee
Dec. XVI/5: Provision of financial assistance to the Methyl Bromide Technical Options Committee
Dec. XVI/6: Accounting framework
Dec. XVI/7: Trade in products and commodities treated with methyl bromide
Dec. XVI/8: Request for technical and financial support relating to methyl bromide alternatives
Dec. XVI/9: Flexibility in the use of alternatives for the phasing out of methyl bromide
Dec. XVI/10: Reporting of information relating to quarantine and pre-shipment uses of methyl bromide
Dec. XVI/11: Coordination among United Nations bodies on quarantine and pre-shipment uses
Dec. XVI/12: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol for controlled substances for 2005 and 2006
Dec. XVI/13: Assessment of the portion of the refrigeration service sector made up by chillers and identification of incentives and impediments to the transition to non-CFC equipment
Dec. XVI/14: Sources of carbon tetrachloride emissions and opportunities for reductions
Dec. XVI/15: Review of approved destruction technologies pursuant to decision XIV/6 of the Parties
Dec. XVI/16: Laboratory and analytical uses
Dec. XVI/17: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol l
Dec. XVI/18: Non-compliance with data-reporting requirements under Articles 5 and 7 of the Montreal Protocol by Parties recently ratifying the Montreal Protocol l
Dec. XVI/19: Potential non-compliance with consumption of Annex A, group II, ozone-depleting substances (halons) by Somalia in 2002 and 2003, and request for a plan of action
Dec. XVI/20: Potential non-compliance in 2003 with consumption of the controlled substance in Annex B, group III (methyl chloroform) by Parties operating under paragraph 1 of Article 5, and requests for plans of action
Dec. XVI/21: Non-compliance with the Montreal Protocol by Azerbaijan
Dec. XVI/22: Non-compliance with the Montreal Protocol by Chile
Dec. XVI/23: Non-compliance with the Montreal Protocol by Fiji
Dec. XVI/24: Non-compliance with the Montreal Protocol by Guinea-Bissau
Dec. XVI/25: Non-compliance with the Montreal Protocol by Lesotho
Dec. XVI/26: Non-compliance with the Montreal Protocol by the Libyan Arab Jamahiriya
Dec. XVI/27: Compliance with the Montreal Protocol by Nepal
Dec. XVI/28: Non-compliance with the Montreal Protocol by Oman
Dec. XVI/29: Non-compliance with the Montreal Protocol by Pakistan
Dec. XVI/30: Non-compliance with the Montreal Protocol by Saint Vincent and the Grenadines
Dec. XVI/31: Requests for changes in baseline data
Dec. XVI/32: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XVI/33: Illegal trade in ozone-depleting substances
Dec. XVI/34: Cooperation between the secretariat of the Montreal Protocol and other related conventions and international organizations
Dec. XVI/35: Terms of reference for the study on the 2006-2008 replenishment of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XVI/36: Evaluation and review of the financial mechanism of the Montreal Protocol (decision XV/47)
Dec. XVI/37: Outstanding contributions to the Multilateral Fund
Dec. XVI/38: Need to ensure equitable geographical representation in the Executive Committee of the Multilateral Fund
Dec. XVI/39: Application of Turkmenistan for developing country status under the Montreal Protocol
Dec. XVI/40: Request by Malta to be removed from the list of developing countries under the Montreal Protocol
Dec. XVI/41: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XVI/42: Membership of the Implementation Committee
Dec. XVI/43: Membership of the Executive Committee of the Multilateral Fund
Dec. XVI/44: Financial matters: Financial reports and budgets
Dec. XVI/45: Declaration of 2007 as “International Year of the Ozone Layer”
Dec. XVI/46: Extraordinary Meeting of the Parties
Dec. XVI/47: Seventeenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
1st ExMOP Decisions
Dec. Ex.I/1: Further adjustments relating to the controlled substance in Annex E
Dec. Ex.I/2: Accelerated phase-out of methyl bromide by Article 5 Parties
Dec. Ex.I/3: Critical-use exemptions for methyl bromide for 2005
Dec. Ex.I/4: Conditions for granting and reporting critical-use exemptions for methyl bromide
Dec. Ex.I/5: Review of the working procedures and terms of reference of the Methyl Bromide Technical Options Committee
==== SHOW ALL ====
15th MOP Decisions
Dec. XV/1: Ratification of the Vienna Convention for the Protection of the Ozone Layer, the Montreal Protocol on Substances that Deplete the Ozone Layer and the London, Copenhagen, Montreal and Beijing amendments
Dec. XV/2: Production for basic domestic needs
Dec. XV/3: Obligations of Parties to the Beijing Amendment under Article 4 of the Montreal Protocol with respect to hydrochlorofluorocarbons
Dec. XV/4: Essential use nominations for non-Article 5 Parties for controlled substances for 2004 and 2005
Dec. XV/5: Promoting the closure of essential-use nominations for metered-dose inhalers
Dec. XV/6: List of uses of controlled substances as process agents
Dec. XV/7: Process agents
Dec. XV/8: Laboratory and analytical uses
Dec. XV/9: Status of destruction technologies for ozone-depleting substances and code of good housekeeping
Dec. XV/10: Handling and destruction of foams containing ozone-depleting substances at the end of their life
Dec. XV/11: Plan of action to modify regulatory requirements that mandate the use of halons on new airframes
Dec. XV/12: Use of methyl bromide for the treatment of high-moisture dates
Dec. XV/13: Membership of the Implementation Committee
Dec. XV/14: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XV/15: Earlier reporting of consumption and production data
Dec. XV/16: Non-compliance with data reporting requirements under Article 7, paragraphs 1 and 2 of the Montreal Protocol
Dec. XV/17: Non-compliance with data reporting requirements under Article 7 of the Montreal Protocol by Parties temporarily classified as operating under Article 5 of the Protocol
Dec. XV/18: Non-compliance with data reporting requirement for the purpose of establishing baselines under Article 5, paragraphs 3 and 8 ter (d)
Dec. XV/19: Methodology for submission of requests for revision of baseline data
Dec. XV/20: Report on the establishment of licensing systems under Article 4B of the Montreal Protocoll
Dec. XV/21: Potential non-compliance with consumption of Annex A, group I, ozone-depleting substances (CFCs) by Article 5 Parties for the control period 1 July 2001-31 December 2002, and requests for plans of action
Dec. XV/22: Potential non-compliance with consumption of Annex A, group II, ozone-depleting substances (halons) by Article 5 Parties in 2002, and requests for plans of action
Dec. XV/23: Potential non-compliance with consumption of the Annex C, group II, ozone-depleting substance (hydrobromofluorocarbons) by Morocco in 2002, and request for a plan of action
Dec. XV/24: Potential non-compliance with consumption of the controlled substance in Annex E (methyl bromide) by non-Article 5 Parties in 2002, and requests for plans of action
Dec. XV/25: Potential non-compliance with consumption of the ozone-depleting substance in Annex E (methyl bromide) by Article 5 Parties in 2002, and requests for plans of action
Dec. XV/26: Non-compliance with the Montreal Protocol by Albania
Dec. XV/27: Non-compliance with the Montreal Protocol by Armenia
Dec. XV/28: Non-compliance with the Montreal Protocol by Azerbaijan
Dec. XV/29: Non-compliance with the Montreal Protocol by Bolivia
Dec. XV/30: Non-compliance with the Montreal Protocol by Bosnia and Herzegovina
Dec. XV/31: Non-compliance with the Montreal Protocol by Botswana
Dec. XV/32: Non-compliance with the Montreal Protocol by Cameroon
Dec. XV/33: Non-compliance with the Montreal Protocol by the Democratic Republic of the Congo
Dec. XV/34: Non-compliance with the Montreal Protocol by Guatemala
Dec. XV/35: Non-compliance with the Montreal Protocol by Honduras
Dec. XV/36: Non-compliance with the Montreal Protocol by the Libyan Arab Jamahiriya
Dec. XV/37: Non-compliance with the Montreal Protocol by Maldives
Dec. XV/38: Non-compliance with the Montreal Protocol by Namibia
Dec. XV/39: Non-compliance with the Montreal Protocol by Nepal
Dec. XV/40: Non-compliance with the Montreal Protocol by Papua New Guinea
Dec. XV/41: Non-compliance with the Montreal Protocol by Qatar
Dec. XV/42: Non-compliance with the Montreal Protocol by Saint Vincent and the Grenadines
Dec. XV/43: Non-compliance with the Montreal Protocol by Uganda
Dec. XV/44: Non-compliance with the Montreal Protocol by Uruguay
Dec. XV/45: Non-compliance with the Montreal Protocol by Viet Nam
Dec. XV/46: Membership of the Executive Committee of the Multilateral Fund
Dec. XV/47: Terms of reference for a study on the management of the financial mechanism of the Montreal Protocol
Dec. XV/48: Decision on the report of the Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XV/49: Application for technical and financial assistance from the Global Environment Facility by South Africa
Dec. XV/50: Continued assistance from the Global Environment Facility to countries with economies in transition
Dec. XV/51: Institutional strengthening assistance to countries with economies in transition
Dec. XV/52: Financial matters: Financial reports and budgets
Dec. XV/53: Terms of reference for the Scientific Assessment Panel, the Environmental Effects Assessment Panel and the Technology and Economic Assessment Panel
Dec. XV/54: Categories of assessment to be used by the Technology and Economic Assessment Panel when assessing critical uses of methyl bromide
Dec. XV/55: Co-chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XV/56: Extraordinary Meeting of the Parties
Dec. XV/57: Sixteenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
14th MOP Decisions
Dec. XIV/1: Ratification of the Vienna Convention for the Protection of the Ozone Layer, the Montreal Protocol on Substances that Deplete the Ozone Layer and the London, Copenhagen, Montreal and Beijing Amendments
Dec. XIV/2: Application by Armenia for developing country status under the Montreal Protocol
Dec. XIV/3: Clarification of certain terminology related to controlled substances
Dec. XIV/4: Essential-use nominations for non-Article 5 Parties for controlled substances for 2003 and 2004
Dec. XIV/5: Global database and assessment to determine appropriate measures to complete the transition from chlorofluorocarbon metered-dose inhalers
Dec. XIV/6: Status of destruction technologies of ozone-depleting substances, including an assessment of their environmental and economic performance, as well as their commercial viability
Dec. XIV/7: Monitoring of trade in ozone-depleting substances and preventing illegal trade in ozone-depleting substances
Dec. XIV/8: Consideration of the use of the Globally Harmonized System for the Classification and Labelling of Chemicals that deplete the ozone layer
Dec. XIV/9: The development of policies governing the service sector and final use of chillers
Dec. XIV/10: Relationship between efforts to protect the stratospheric ozone layer and efforts to safeguard the global climate system: issues relating to hydrofluorocarbons and perfluorocarbons
Dec. XIV/11: The relationship between the Montreal Protocol and the World Trade Organization
Dec. XIV/12: Membership of the Implementation Committee
Dec. XIV/13: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XIV/14: Non-compliance with data reporting requirements under Article 7 of the Montreal Protocol by Parties temporarily classified as operating under Article 5 of the Protocol
Dec. XIV/15: Non-compliance with data reporting requirement under Article 7 paragraphs 1 and 2 of the Montreal Protocol
Dec. XIV/16: Non-compliance with data reporting requirement for the purpose of establishing baselines under Article 5 paragraphs 3 and 8 ter (d)
Dec. XIV/17: Potential non-compliance with the freeze on CFC consumption by Parties operating under Article 5 for the control period July 2000 to June 2001
Dec. XIV/18: Non-compliance with the Montreal Protocol by Albania
Dec. XIV/19: Non-compliance with the Montreal Protocol by Bahamas
Dec. XIV/20: Non-compliance with the Montreal Protocol by Bolivia
Dec. XIV/21: Non-compliance with the Montreal Protocol by Bosnia and Herzegovina
Dec. XIV/22: Non-compliance with the Montreal Protocol by Namibia
Dec. XIV/23: Non-compliance with the Montreal Protocol by Nepal
Dec. XIV/24: Non-compliance with the Montreal Protocol by Saint Vincent and the Grenadines
Dec. XIV/25: Non-compliance with the Montreal Protocol by Libyan Arab Jamahiriya
Dec. XIV/26: Non-compliance with the Montreal Protocol by Maldives
Dec. XIV/27: Requests for changes in baseline data
Dec. XIV/28: Non-compliance with consumption phase-out by Parties not operating under Article 5 in 2000
Dec. XIV/29: Non-compliance with the Montreal Protocol by Bangladesh
Dec. XIV/30: Non-compliance with the Montreal Protocol by Nigeria
Dec. XIV/31: Non-compliance with the Montreal Protocol by Armenia
Dec. XIV/32: Non-compliance with the Montreal Protocol by Cameroon
Dec. XIV/33: Non-compliance with the Montreal Protocol by Belize
Dec. XIV/34: Non-compliance with the Montreal Protocol by Ethiopia
Dec. XIV/35: Compliance with the Montreal Protocol by the Russian Federation
Dec. XIV/36: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol
Dec. XIV/37: Interaction between the Executive Committee and the Implementation Committee
Dec. XIV/38: Membership of the Executive Committee of the Multilateral Fund
Dec. XIV/39: The 2003-2005 replenishment of the Multilateral Fund
Dec. XIV/40: Fixed-Exchange-Rate Mechanism for the replenishment of the Multilateral Fund
Dec. XIV/41: Financial matters: Financial reports and budgets
Dec. XIV/42: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XIV/43: Fifteenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
13th MOP Decisions
Dec. XIII/1: Terms of reference for the study on the 2003-2005 replenishment of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XIII/2: Ad hoc working group on the 2003-2005 replenishment of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. XIII/3: Evaluation study on the managing and implementing bodies of the financial mechanism of the Montreal Protocol
Dec. XIII/4: Review of the implementation of the fixed-exchange-rate mechanism and determination of the impact of the mechanism on the operations of the Multilateral Fund for the Implementation of the Montreal Protocol and on the funding of the phase-out of ozone-depleting substances in Article 5 Parties for the triennium 2000-2002
Dec. XIII/5: Procedures for assessing the ozone-depleting potential of new substances that may be damaging to the ozone layer
Dec. XIII/6: Expedited procedures for adding new substances to the Montreal Protocol
Dec. XIII/7: n-propyl bromide
Dec. XIII/8: Essential-use nominations for non-Article 5 Parties for controlled substances for the year 2002 and beyond
Dec. XIII/9: Metered-dose inhaler (MDI) production
Dec. XIII/10: Further study of campaign production of CFCs for metered-dose inhalers (MDIs)
Dec. XIII/11: Procedures for applying for a critical-use exemption for methyl bromide
Dec. XIII/12: Monitoring of international trade and prevention of illegal trade in ozone-depleting substances, mixtures and products containing ozone-depleting substances
Dec. XIII/13: Request to the Technology and Economic Assessment Panel for the final report on process agents
Dec. XIII/14: Ratification of the Vienna Convention for the Protection of the Ozone Layer, the Montreal Protocol on Substances that Deplete the Ozone Layer and the London, Copenhagen, Montreal and Beijing Amendments
Dec. XIII/15: Data and information provided by the Parties to the 13th Meeting of the Parties in accordance with Article 7 of the Montreal Protocol
Dec. XIII/16: Potential non-compliance with the freeze on CFC consumption in Article 5 Parties in the control period 1999-2000
Dec. XIII/17: Compliance with the Montreal Protocol by the Russian Federation
Dec. XIII/18: Compliance with the Montreal Protocol by Armenia
Dec. XIII/19: Compliance with the Montreal Protocol by Kazakhstan
Dec. XIII/20: Compliance with the Montreal Protocol by Tajikistan
Dec. XIII/21: Compliance with the Montreal Protocol by Argentina
Dec. XIII/22: Compliance with the Montreal Protocol by Belize
Dec. XIII/23: Compliance with the Montreal Protocol by Cameroon
Dec. XIII/24: Compliance with the Montreal Protocol by Ethiopia
Dec. XIII/25: Compliance with the Montreal Protocol by Peru
Dec. XIII/26: Membership of the Implementation Committee
Dec. XIII/27: Membership of the Executive Committee of the Multilateral Fund
Dec. XIII/28: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XIII/29: Recognizing the preparations for the World Summit on Sustainable Development 2002
Dec. XIII/30: Financial matters: Financial reports and budgets
Dec. XIII/31: Appointment of the Executive Secretary of the Ozone Secretariat
Dec. XIII/32: Colombo Declaration
Dec. XIII/33: Fourteenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
12th MOP Decisions
Dec. XII/1: Methyl bromide production by non-Article 5 Parties for basic domestic needs in 2001
Dec. XII/2: Measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers
Dec. XII/3: Membership of the Implementation Committee
Dec. XII/4: Membership of the Executive Committee of the Multilateral Fund
Dec. XII/5: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XII/6: Data and information provided by the Parties in accordance with Articles 7 and 9 of the Montreal Protocol
Dec. XII/7: Ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing Amendments
Dec. XII/8: Disposal of controlled substances
Dec. XII/9: Essential-use nominations for non-Article 5 Parties for controlled substances for 2001 and 2002
Dec. XII/10: Monitoring of international trade and prevention of illegal trade in ozone-depleting substances, mixtures and products containing ozone-depleting substances
Dec. XII/11: Application by Kyrgyzstan for developing country status under the Montreal Protocol
Dec. XII/12: Request by Slovenia to be removed from the list of developing counties under the Montreal Protocol
Dec. XII/13: Term of office of the Implementation Committee and its officers
Dec. XII/14: Continued assistance from the Global Environment Facility to countries with economies in transition
Dec. XII/15: Financial matters: Financial report and budgets
Dec. XII/16: Organization of Ozone Secretariat and Multilateral Fund meetings
Dec. XII/17: Ouagadougou Declaration at the Twelfth Meeting of the Parties to the Montreal Protocol
Dec. XII/18: Thirteenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
11th MOP Decisions
Dec. XI/1: Beijing Declaration on Renewed Commitment to the Protection of the Ozone Layer
Dec. XI/2: Further adjustments with regard to Annex A substances
Dec. XI/3: Further adjustments with regard to Annex B substances
Dec. XI/4: Further adjustments with regard to Annex E substance
Dec. XI/5: Further Amendment of the Montreal Protocol
Dec. XI/6: Fixed-exchange-rate mechanism for the replenishment of the Multilateral Fund
Dec. XI/7: Replenishment of the Multilateral Fund for the period 2000-2002
Dec. XI/8: Membership of the Implementation Committee
Dec. XI/9: Membership of the Executive Committee of the Multilateral Fund
Dec. XI/10: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. XI/11: Ratification of the Vienna Convention, the Montreal Protocol, and the London, Copenhagen and Montreal Amendments
Dec. XI/12: Definition of pre-shipment applications of methyl bromide
Dec. XI/13: Quarantine and pre-shipment
Dec. XI/14: Essential-use nominations for non-Article 5 Parties for controlled substances for 2000 and 2001
Dec. XI/15: Global exemption for laboratory and analytical uses
Dec. XI/16: CFC management strategies in non-Article 5 Parties
Dec. XI/17: Terms of reference for Assessment Panels
Dec. XI/18: Special Report on Aviation and the Global Atmosphere
Dec. XI/19: Assessment of new substances
Dec. XI/20: Procedure for new substances
Dec. XI/21: Financial matters: financial report and budgets
Dec. XI/22: Global Environment Facility
Dec. XI/23: Data reporting
Dec. XI/24: Compliance with the Montreal Protocol by Bulgaria
Dec. XI/25: Compliance with the Montreal Protocol by Turkmenistan
Dec. XI/26: Recommendations and clarifications of the World Customs Organization concerning customs codes for ozone-depleting substances and products containing ozone-depleting substances
Dec. XI/27: Refrigerant management plans
Dec. XI/28: Supply of HCFCs to Parties operating under paragraph 1 Article 5 of the Protocol
Dec. XI/29: Twelfth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
10th MOP Decisions
Dec. X/1: Ratification of the Vienna Convention, Montreal Protocol, London, Copenhagen and Montreal Amendments
Dec. X/2: Data and information provided by the Parties in accordance with Articles 7 and 9 of the Montreal Protocol
Dec. X/3: Membership of the Implementation Committee
Dec. X/4: Membership of the Executive Committee of the Multilateral Fund
Dec. X/5: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. X/6: Essential-use nominations for non-Article 5 Parties for controlled substances for 1999 and 2000
Dec. X/7: Halon-management strategies
Dec. X/8: New substances with ozone-depleting potential
Dec. X/9: Establishment of a list of countries that do not manufacture for domestic use and do not wish to import products and equipment whose continuing functioning relies on Annex A and Annex B substances
Dec. X/10: Review of the non-compliance procedure
Dec. X/11: Quarantine and pre-shipment exemption
Dec. X/12: Emissions of ozone-depleting substances from feedstock applications
Dec. X/13: Terms of reference for a study on the 2000-2002 replenishment of the Multilateral Fund
Dec. X/14: Process agents
Dec. X/15: Exports of controlled substances in Annex A and Annex B to the Montreal Protocol from non-Article 5 Parties to meet the basic domestic needs of Article 5 Parties
Dec. X/16: Implementation of the Montreal Protocol in the light of the Kyoto Protocol
Dec. X/17: Production sector
Dec. X/18: Customs codes
Dec. X/19: Exemption for laboratory and analytical uses
Dec. X/20: Compliance with the Montreal Protocol by Azerbaijan
Dec. X/21: Compliance with the Montreal Protocol by Belarus
Dec. X/22: Compliance with the Montreal Protocol by the Czech Republic
Dec. X/23: Compliance with the Montreal Protocol by Estonia
Dec. X/24: Compliance with the Montreal Protocol by Latvia
Dec. X/25: Compliance with the Montreal Protocol by Lithuania
Dec. X/26: Compliance with the Montreal Protocol by the Russian Federation
Dec. X/27: Compliance with the Montreal Protocol by Ukraine
Dec. X/28: Compliance with the Montreal Protocol by Uzbekistan
Dec. X/29: Inconsistencies in the timing for the reporting of data under Article 7 and for monitoring compliance with the phase-out schedule under Article 5, paragraph 8 bis
Dec. X/30: Financial matters: financial report and budgets
Dec. X/31: Measures taken to improve the Financial Mechanism and technology transfer
Dec. X/32: Proposal to study a fixed currency exchange rate mechanism for the replenishment of the Multilateral Fund
Dec. X/33: Global Environment Facility
Dec. X/34: Eleventh Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
9th MOP Decisions
Dec. IX/1: Further adjustments with regard to Annex A substances
Dec. IX/2: Further adjustments with regard to Annex B substances
Dec. IX/3: Further adjustments and reductions with regard to the Annex E substance
Dec. IX/4: Further Amendment of the Protocol
Dec. IX/5: Conditions for control measures on Annex E substance in Article 5 Parties
Dec. IX/6: Critical-use exemptions for methyl bromide
Dec. IX/7: Emergency methyl-bromide use
Dec. IX/8: Licensing system
Dec. IX/9: Control of export of products and equipment whose continuing functioning relies on Annex A and Annex B substances
Dec. IX/10: Ratification of the Vienna Convention, Montreal Protocol and London and Copenhagen Amendments
Dec. IX/11: Data and information provided by the Parties in accordance with Articles 7 and 9 of the Montreal Protocol
Dec. IX/12: Membership of the Implementation Committee
Dec. IX/13: Membership of the Executive Committee of the Multilateral Fund
Dec. IX/14: Measures taken to improve the Financial Mechanism and technology transfer
Dec. IX/15: Production sector
Dec. IX/16: Terms of reference of the Executive Committee
Dec. IX/17: Essential-use exemption for laboratory and analytical uses of ozone-depleting substances
Dec. IX/18: Essential-use nominations for non-Article 5 Parties for controlled substances for 1998 and 1999
Dec. IX/19: Metered-dose inhalers (MDIs)
Dec. IX/20: Transfer of essential-use authorizations for CFCs for MDIs
Dec. IX/21: Decommissioning of non-essential halon systems in non-Article 5 Parties
Dec. IX/22: Customs codes
Dec. IX/23: Continuing availability of CFCs
Dec. IX/24: Control of new substances with ozone-depleting potential
Dec. IX/25: Special Report on Aviation and the Global Atmosphere
Dec. IX/26: Application of the Republic of Moldova for developing country status under the Montreal Protocol
Dec. IX/27: Application of South Africa for developing country status under the Montreal Protocol
Dec. IX/28: Revised formats for reporting data under Article 7 of the Protocol
Dec. IX/29: Compliance with the Montreal Protocol by Latvia
Dec. IX/30: Compliance with the Montreal Protocol by Lithuania
Dec. IX/31: Compliance with the Montreal Protocol by the Russian Federation
Dec. IX/32: Non-compliance by the Czech Republic with the freeze in consumption of methyl bromide in 1995
Dec. IX/33: Request by Brunei Darussalam for reclassification as a Party operating under paragraph 1 of Article 5
Dec. IX/34: Compliance with the Montreal Protocol
Dec. IX/35: Review of the non-compliance procedure
Dec. IX/36: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. IX/37: Financial matters: financial report and budgets
Dec. IX/38: Outstanding contributions to the Multilateral Fund from Parties not operating under Article 5 that had not ratified the London Amendment
Dec. IX/39: Refund of contributions by Cyprus to the Multilateral Fund
Dec. IX/40: Tenth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
8th MOP Decisions
Dec. VIII/1: Ratification of the Vienna Convention, the Montreal Protocol and its Amendments
Dec. VIII/2: Data and information provided by the Parties in accordance with Articles 7 and 9 of the Montreal Protocol
Dec. VIII/3: Membership of the Implementation Committee
Dec. VIII/4: Replenishment of the Multilateral Fund and three-year rolling business plan for 1997-99
Dec. VIII/5: Actions to improve the functioning of the Financial Mechanism
Dec. VIII/6: Contributions to the Multilateral Fund
Dec. VIII/7: Measures taken to improve the Financial Mechanism and technology transfer
Dec. VIII/8: Membership of the Executive Committee of the Multilateral Fund
Dec. VIII/9: Essential-use nominations for Parties not operating under Article 5 for controlled substances for 1997 through 2002
Dec. VIII/10: Actions by Parties not operating under Article 5 to promote industry’s participation on a smooth and efficient transition away from CFC-based MDIs
Dec. VIII/11: Measures to facilitate a transition by a Party not operating under Article 5 from CFC-based MDIs
Dec. VIII/12: Information gathering on a transition to non-CFC treatments for asthma and chronic obstructive pulmonary disease for Parties not operating under Article 5
Dec. VIII/13: Uses and possible applications of hydrochlorofluorocarbons (HCFCs)
Dec. VIII/14: Further clarification of the definition of “Bulk substances” under decision I/12A
Dec. VIII/15: Control of trade in methyl bromide with non-Parties
Dec. VIII/16: Critical agricultural uses of methyl bromide
Dec. VIII/17: Availability of halons for critical uses
Dec. VIII/18: List of products containing controlled substances in Group II of Annex C (Hydrobromofluorocarbons) of the Protocol
Dec. VIII/19: Organization and functioning of the Technology and Economic Assessment Panel
Dec. VIII/20: Illegal imports and exports of controlled substances
Dec. VIII/21: Revised formats for reporting data under Article 7 of the Protocol
Dec. VIII/22: Compliance with the Montreal Protocol by Latvia
Dec. VIII/23: Compliance with the Montreal Protocol by Lithuania
Dec. VIII/24: Non-compliance by the Czech Republic with the halon phase-out by 1994
Dec. VIII/25: Compliance with the Montreal Protocol by the Russian Federation
Dec. VIII/26: Exports of ozone-depleting substances and products containing ozone-depleting substances
Dec. VIII/27: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. VIII/28: Financial Matters: financial report and budgets
Dec. VIII/29: Application of Georgia for developing country status under the Montreal Protocol
Dec. VIII/30: Ninth Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
7th MOP Decisions
Dec. VII/1: Further adjustments and reductions: controlled substances listed in Annex A to the Protocol
Dec. VII/2: Further adjustments and reductions: controlled substances listed in Annex B to the Protocol
Dec. VII/3: Further adjustments and reductions: controlled substances listed in Annexes C and E to the Protocol
Dec. VII/4: Provision of financial support and technology transfer
Dec. VII/5: Definition of “quarantine” and “pre-shipment applications”
Dec. VII/6: Reduction of methyl bromide emissions
Dec. VII/7: Trade in methyl bromide
Dec. VII/8: Review of methyl bromide controls
Dec. VII/9: Basic domestic needs
Dec. VII/10: Continued uses of controlled substances as chemical process agents after 1996
Dec. VII/11: Laboratory and analytical uses
Dec. VII/12: Control measures for Parties not operating under Article 5 concerning halons and other agents used for fire-suppression and explosion-inertion purposes
Dec. VII/13: Ratification, approval or accession to the Vienna Convention for the Protection of the Ozone Layer, the Montreal Protocol on Substances that Deplete the Ozone Layer and the Amendments to the Montreal Protocol
Dec. VII/14: Implementation of the Protocol by the Parties
Dec. VII/15: Compliance with the Montreal Protocol by Poland
Dec. VII/16: Compliance with the Montreal Protocol by Bulgaria
Dec. VII/17: Compliance with the Montreal Protocol by Belarus
Dec. VII/18: Compliance with the Montreal Protocol by the Russian Federation
Dec. VII/19: Compliance with the Montreal Protocol by Ukraine
Dec. VII/20: Discrepancy between the data reported by a Party to the Ozone Secretariat and the data presented by that Party to the Executive Committee of the Multilateral Fund
Dec. VII/21: Membership of the Implementation Committee
Dec. VII/22: Review of the Financial Mechanism
Dec. VII/23: Financial planning in the Multilateral Fund
Dec. VII/24: 1997-1999 replenishment of the Multilateral Fund
Dec. VII/25: Provision by the Executive Committee of the Multilateral Fund of specific financial support for projects in low-volume-ODS-consuming countries (LVCs)
Dec. VII/26: Technology transfer
Dec. VII/27: Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. VII/28: Essential-use nominations for controlled substances for 1996 and beyond
Dec. VII/29: Assessment of the possible need for and modalities and criteria for a critical agricultural use exemption for methyl bromide
Dec. VII/30: Export and import of controlled substances to be used as feedstock
Dec. VII/31: Status of recycled CFCs and halons under the Basel Convention on the Control of Transboundary Movements of Hazardous Wastes and their Disposal
Dec. VII/32: Control of export and import of products and equipment containing substances listed in Annexes A and B of the Montreal Protocol
Dec. VII/33: Illegal imports and exports of controlled substances
Dec. VII/34: Assessment Panels
Dec. VII/35: Destruction technology
Dec. VII/36: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. VII/37: Financial matters: financial report and budgets
Dec. VII/38: Eighth, Ninth and Tenth Meetings of the Parties to the Montreal Protocol
==== SHOW ALL ====
6th MOP Decisions
Dec. VI/1: Ratification, approval or accession to the Vienna Convention for the Protection of the Ozone Layer, the Montreal Protocol on Substances that Deplete the Ozone Layer and the Amendments to the Montreal Protocol
Dec. VI/2: Implementation of Article 7 and 9 of the Protocol
Dec. VI/3: Implementation Committee
Dec. VI/4: Application of trade measures under Article 4 to non-Parties to the London Amendment to the Protocol
Dec. VI/5: Status of certain Parties vis-à-vis Article 5 of the Protocol
Dec. VI/6: Reviews under paragraph 8 of Article 5 of the Protocol and under section II, paragraph 4, of decision IV/18 of the Fourth Meeting of the Parties to the Montreal Protocol
Dec. VI/7: Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. VI/8: Essential-use nominations for halons for 1995
Dec. VI/9: Essential-use nominations for controlled substances other than halons for 1996 and beyond
Dec. VI/10: Use of controlled substances as process agents
Dec. VI/11: Clarification of “quarantine” and “pre-shipment” applications for control of methyl bromide
Dec. VI/12: List of products containing controlled substances in Annex B of the Protocol
Dec. VI/13: Assessment Panels
Dec. VI/14A: Provision of information on the supply of controlled substances to Parties operating under paragraph 1 of Article 5 of the Montreal Protocol
Dec. VI/14B: “Basic domestic needs”
Dec. VI/15: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol
Dec. VI/16: Juridical personality, privileges and immunities of the Multilateral Fund
Dec. VI/17: Budgets and financial matters
Dec. VI/18: Modification of the indicative list of categories of incremental costs under the Montreal Protocol
Dec. VI/19: Trade in previously used ozone-depleting substances
Dec. VI/20: Seventh Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
5th MOP Decisions
Dec. V/1: Amendments adopted by the Second Meeting of the Parties (London Amendment) and by the Fourth Meeting of the Parties (Copenhagen Amendment)
Dec. V/2: Implementation Committee
Dec. V/3: Application of trade measures under Article 4 to non-Parties to the London Amendment
Dec. V/4: Classification of certain developing countries as not operating under Article 5 and reclassification of certain developing countries earlier classified as not operating under Article 5
Dec. V/5: Revised format for reporting of data under Article 7
Dec. V/6: Data and information reporting
Dec. V/7: Review of the functioning of the Financial Mechanism since 1 January 1991
Dec. V/8: Consideration of alternatives
Dec. V/9: Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. V/10: Temporary difficulties encountered by Hungary, Bulgaria, Poland and other countries with economies in transition
Dec. V/11: Review under paragraph 8 of Article 5 of the Protocol
Dec. V/12: Review under section II, paragraph 4, of decision IV/18 of the Fourth Meeting of the Parties to the Montreal Protocol
Dec. V/13: Assessment Panel reports
Dec. V/14: Essential uses of halons
Dec. V/15: International halon bank management
Dec. V/16: Supply of halons to Parties operating under paragraph 1 of Article 5 of the Protocol
Dec. V/17: Feasibility of banning or restricting from States not party to the Montreal Protocol the import of products produced with, but not containing, controlled substances in Annex A, in accordance with paragraph 4 of Article 4 of the Protocol
Dec. V/18: Timetable for the submission and consideration of essential-use nominations
Dec. V/19: Control measures to be applicable to Parties operating under paragraph 1 of Article 5 of the Protocol with respect to the controlled substances in Group I of Annex C, Group II of Annex C, and Annex E
Dec. V/20: Extension of application of trade measures under Article 4 to controlled substances listed in Group I of Annex C and in Annex E
Dec. V/21: Budgets and financial matters
Dec. V/22: Bureau of the Fourth Meeting of the Parties to the Montreal Protocol
Dec. V/23: Funding of methyl bromide projects by the Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol
Dec. V/24: Trade in controlled substances and the Basel Convention on Transboundary Movement of Hazardous Wastes and their Disposal
Dec. V/25: Provision of information on the supply of controlled substances to Parties operating under paragraph 1 of Article 5 of the Montreal Protocol
Dec. V/26: Destruction Technologies
Dec. V/27: Sixth Meeting of the Parties to the Montreal Protocol
Dec. V/28: Seventh Meeting of the Parties to the Montreal Protocol
==== SHOW ALL ====
4th MOP Decisions
Dec. IV/1: Amendment adopted by the Second Meeting of the Parties (London Amendment)
Dec. IV/2: Further adjustments and reductions
Dec. IV/3: Further adjustments and reductions
Dec. IV/4: Further Amendment of the Protocol
Dec. IV/5: Non-compliance procedure
Dec. IV/6: Implementation Committee
Dec. IV/7: Definition of developing countries
Dec. IV/8: Participation of developing countries
Dec. IV/9: Data and information reporting
Dec. IV/10: Trade names of controlled substances
Dec. IV/11: Destruction technologies
Dec. IV/12: Clarification of the definition of controlled substances
Dec. IV/13: Assessment panels
Dec. IV/14: Transshipment of controlled substances
Dec. IV/15: Situation whereby Parties operating under paragraph 1 of Article 5 exceed the consumption limit set in that Article
Dec. IV/16: Annex D to the Montreal Protocol
Dec. IV/17A: Trade issues
Dec. IV/17B: Application to Colombia of paragraph 8 of Article 4 of the amended Montreal Protocol
Dec. IV/17C: Application of trade measures under Article 4 to non-Parties to the Protocol
Dec. IV/18: Financial mechanism
Dec. IV/19: Budgets and financial matters
Dec. IV/20: Executive Committee of the Multilateral Fund
Dec. IV/21: Temporary difficulties encountered by Hungary, Bulgaria and Poland
Dec. IV/22: Bureau of the Montreal Protocol
Dec. IV/23: Methyl bromide
Dec. IV/24: Recovery, reclamation and recycling of controlled substances
Dec. IV/25: Essential uses
Dec. IV/26: International recycled halon bank management
Dec. IV/27: Implementation of paragraph 4 of Article 4 of the Protocol
Dec. IV/28: Implementation of paragraph 3 bis of Article 4 of the Protocol
Dec. IV/29: Meeting the needs of Parties operating under paragraph 1 of Article 5 of the Protocol
Dec. IV/30: Hydrochlorofluorocarbons (HCFCs)
Dec. IV/31: Fifth Meeting of the Parties to the Montreal Protocol
Dec. IV/18(5) - Annex X: Terms of Reference of the Executive Committee
Dec. IV/18(5) - Annex IX: Terms of Reference for the Multilateral Fund
==== SHOW ALL ====
3rd MOP Decisions
Dec. III/1: Adjustments and amendment
Dec. III/2: Non-compliance procedure
Dec. III/3: Implementation Committee
Dec. III/4: Montreal Protocol Handbook
Dec. III/5: Definition of developing countries
Dec. III/6: Participation of developing countries
Dec. III/7: Data reporting
Dec. III/8: Trade names of controlled substances
Dec. III/9: Formats for reporting data under the amended Protocol
Dec. III/10: Destruction technologies
Dec. III/11: Open-ended Working Group of the Parties
Dec. III/12: Assessment Panels
Dec. III/13: Further adjustments to and amendments of the Montreal Protocol
Dec. III/14: Amendment of the Rules of Procedure
Dec. III/15: Annex to the Montreal Protocol
Dec. III/16: Trade Issues
Dec. III/17: Amendment of the Vienna Convention
Dec. III/18: Fourth Meeting of the Parties to the Montreal Protocol
Dec. III/19: Financial mechanism
Dec. III/20: Composition of the Implementation Committee
Dec. III/21: Budgets and financial matters
Dec. III/22: Executive Committee of the Multilateral Fund
==== SHOW ALL ====
2nd MOP Decisions
Dec. II/1: Adjustments and reductions
Dec. II/2: Amendment of the Protocol
Dec. II/3: Halons
Dec. II/4: Isomers
Dec. II/5: Non-compliance
Dec. II/6: Article 19 (Withdrawal)
Dec. II/7: Montreal Protocol Handbook
Dec. II/8: Financial mechanism
Dec. II/8A: Budget for the Fund Secretariat
Dec. II/8B: Acceptance of the offer of Canada
Dec. II/9: Data reporting
Dec. II/10: Data of developing countries
Dec. II/11: Destruction technologies
Dec. II/12: Customs Co-operation Council
Dec. II/13: Assessment panels
Dec. II/14: Workplans required by Articles 9 and 10 of the Protocol
Dec. II/15: Extension of the mandate of the Open-ended Working Group of the Parties
Dec. II/16: Amendment of the Vienna Convention
Dec. II/17: Budget
Dec. II/18: Meetings of the Open-ended Working Group
Dec. II/19: Rules of procedure for meetings of the Parties
Dec. II/20: Third Meeting of the Parties
==== SHOW ALL ====
1st MOP Decisions
Dec. I/1: Rules of procedure for Meetings of the Parties
Dec. I/2: Establishment of Bureau
Dec. I/3: Establishment of Assessment Panels
Dec. I/4: Workplans required by Articles 9 and 10 of the Protocol
Dec. I/5: Establishment of Open-ended Working Group
Dec. I/6: Meetings of Open-ended Working Group
Dec. I/7: Participation by non-Parties
Dec. I/8: Non-compliance
Dec. I/9: ODP for halon 2402
Dec. I/10: Characteristics of relevant substances
Dec. I/11: Report and confidentiality of data
Dec. I/12A: Clarification of terms and definitions: Controlled substances (in bulk)
Dec. I/12B: Clarification of terms and definitions: Controlled substances produced
Dec. I/12C: Clarification of terms and definitions: Basic domestic needs
Dec. I/12D: Clarification of terms and definitions: Industrial rationalization
Dec. I/12E: Clarification of terms and definitions: developing countries
Dec. I/12F: Clarification of terms and definitions: Destruction
Dec. I/12G: Clarification of terms and definitions: Article 2, paragraph 6
Dec. I/12H: Clarification of terms and definitions: Exports and imports of used controlled substances
Dec. I/13: Assistance to developing countries
Dec. I/14: Financial arrangements
Dec. I/15: Helsinki Declaration
==== SHOW ALL ====